Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Oosting, Sjoukje F."'
Autor:
Voss MH; Memorial Sloan Kettering Cancer Center, New York, New York., Azad AA; Monash Health, Melbourne, Australia., Hansen AR; Princess Margaret Cancer Centre, Toronto, Canada., Gray JE; Moffitt Cancer Center, Tampa, Florida., Welsh SJ; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Song X; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Kuziora M; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Meinecke L; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Blando J; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Achour I; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Wang Y; Early Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Walcott FL; Oncology R&D, AstraZeneca, Gaithersburg, Maryland., Oosting SF; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jul 15; Vol. 28 (14), pp. 3032-3041.
Autor:
Stelwagen J; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Lubberts S; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Steggink LC; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Steursma G; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Kruyt LM; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Donkerbroek JW; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., van Roon AM; Department of Internal Medicine, division of Vascular Medicine, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., van Gessel AI; Department of Internal Medicine, division of Vascular Medicine, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., van de Zande SC; Department of Internal Medicine, division of Vascular Medicine, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Meijer C; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Gräfin Zu Eulenburg CH; Department of Epidemiology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Oosting SF; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Nuver J; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Walenkamp AME; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Jan de Jong I; Department of Urology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Lefrandt JD; Department of Internal Medicine, division of Vascular Medicine, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Gietema JA; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands. j.a.gietema@umcg.nl.
Publikováno v:
British journal of cancer [Br J Cancer] 2020 Nov; Vol. 123 (11), pp. 1599-1607. Date of Electronic Publication: 2020 Sep 14.
Autor:
Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: motzerr@mskcc.org., Rini BI; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA., McDermott DF; Department of Hematology and Medical Oncology, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, MA, USA., Arén Frontera O; Department of Medical Oncology, Centro de Invetigación Clínica Bradford Hill, Santiago, Chile., Hammers HJ; Department of Oncology and Urology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Carducci MA; Department of Oncology and Urology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Salman P; Department of Medical Oncology, Fundación Arturo López Pérez, Santiago, Chile., Escudier B; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Beuselinck B; Department of Oncology, University Hospitals Leuven, Leuven, Belgium., Amin A; Levine Cancer Institute, Atrium Healthcare, Charlotte, NC, USA., Porta C; Department of Medical Oncology, IRCCS San Matteo University Hospital Foundation, Pavia, Italy., George S; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA., Neiman V; Department of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel; Tel Aviv University, Tel Aviv, Israel., Bracarda S; Department of Oncology, Ospedale San Donato, Azienda USL Toscana Sud-Est, IstitutoToscanoTumori, Arezzo, Italy., Tykodi SS; Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Barthélémy P; Department of Medical Oncology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Leibowitz-Amit R; Oncology Department, Sheba Medical Center, Ramat Gan, Israel., Plimack ER; Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Redman B; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA., Melichar B; Department of Oncology, Palacky University, and University Hospital Olomouc, Olomouc, Czech Republic., Powles T; Department of Genitourinary Oncology, Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free National Health Service Trust, London, UK., Nathan P; Department of Cancer Services: Oncology, Mount Vernon Cancer Centre, Northwood, Middlesex, UK., Oudard S; Department of Medical Oncology, Service de Cancérologie Médicale Hôpital Européen Georges Pompidou, Paris, France., Pook D; Department of Oncology, Monash Health, Melbourne, VIC, Australia., Choueiri TK; Department of Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Donskov F; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Grimm MO; Department of Urology, Jena University Hospital, Jena, Germany., Gurney H; Department of Medical Oncology, Westmead Hospital and Macquarie University, Sydney, NSW, Australia., Heng DYC; Department of Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, AB, Canada., Kollmannsberger CK; Department of Medicine, British Columbia Cancer Agency, Vancouver, BC, Canada., Harrison MR; Division of Medical Oncology, Duke Cancer Institute, Durham, NC, USA., Tomita Y; Department of Urology, Niigata University, Niigata, Japan., Duran I; Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain., Grünwald V; Interdisciplinary Genitourinary Oncology at the West-German Cancer Center, Clinic for Internal Medicine (Tumor Research) and Clinic for Urology, University Hospital Essen, Essen, Germany., McHenry MB; Bristol-Myers Squibb, Princeton, NJ, USA., Mekan S; Bristol-Myers Squibb, Princeton, NJ, USA., Tannir NM; Department of Genitourinary Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Oct; Vol. 20 (10), pp. 1370-1385. Date of Electronic Publication: 2019 Aug 16.
Autor:
Nuver J; Universitair Medisch Centrum Groningen, afd. Medische Oncologie, Groningen, the Netherlands., Oosting SF, Gietema JA
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2011; Vol. 155 (45), pp. A4092.
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 155(45). NLM (Medline)
Testicular carcinoma is a rare tumour but the most frequently occurring form of cancer in men aged 18-35 years. In metastatic disease, following orchidectomy three or four courses of combination chemotherapy with cisplatin are given. With a general c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::943f7b15c18d8d2ad35c72dc9a7132d7
https://research.rug.nl/en/publications/aafdd78d-902b-4bcd-921e-974637e639e9
https://research.rug.nl/en/publications/aafdd78d-902b-4bcd-921e-974637e639e9